Showing results (141-150 of 212) with videos related to
Sort By:
Pageof 22
Cancers|July 26, 2020
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19Nicolas Duployez, Jordane Demonchy, Céline Berthon, et al.Blood|March 22, 2024
Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALLEstelle Balducci, Mathieu Simonin, Nicolas Duployez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First RemissionXavier Thomas, Stéphane de Botton, Sylvie Chevret, et al.American Journal of Hematology|May 29, 2015
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosisCharles Herbaux, Nicolas Duployez, Catherine Badens, et al.Lancet (London, England)|April 10, 2012
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studySylvie Castaigne, Cécile Pautas, Christine Terré, et al.Blood|August 11, 2011
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trialThorsten Braun, Raphael Itzykson, Aline Renneville, et al.The New England Journal of Medicine|December 24, 2010
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemiaClaude Preudhomme, Joëlle Guilhot, Franck Emmanuel Nicolini, et al.Blood|February 15, 2007
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJelena V Jovanovic, Joannah Score, Katherine Waghorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association GroupMarie Balsat, Aline Renneville, Xavier Thomas, et al.Haematologica|February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureMarie Sébert, Aline Renneville, Cécile Bally, et al.Pageof 22